USUS exceptionalism will persist, says Dr DoomEsteemed economist Nouriel Roubini, who sports the nickname ‘Dr Doom’, is predicting a brighter futureSave2 December 2025
Alpha Investment PortfoliosYen ‘carry’ trade is something for investors to fret overWe discuss updates to our successful multi-asset portfoliosSave1 December 2025
Pensions & RetirementHow to protect your retirement after the Budget Introducing a salary sacrifice relief cap limits the options for pension savers. However, there are steps you can take to stay on trackSave1 December 2025
Results & Trading UpdatesImpax hit by £13bn outflow as active managers struggleThe sustainability-focused asset manager has to recalibrate after another wave of outflowsSave1 December 2025
Tech StocksThe AI believers who are happy with valuationsThe AI narrative is starting to change, but there are still plenty of optimists out thereSave1 December 2025
Small Companies & AIMThis defence small cap is back on trackSimon Thompson: The group is winning new orders and a modest rating fails to reflect its tractionSave1 December 2025
The TraderFTSE bucks the risk-off trendUpdates on world markets and companies newsSave1 December 2025
Results & Trading UpdatesMitchells & Butlers: Pricier pints power profit growthShares in the FTSE 250 pub and restaurant operator rose 10 per cent on final results daySave28 November 2025
Director DealsSainsbury’s and Bridgepoint: Big director share deals this weekFind out which directors are buying and selling shares in their own companiesSave28 November 2025
The Stock Market Week AheadVictrex & AJ Bell: Stock market week ahead – 1-5 DecemberA summary of key company announcements expected in the coming weekSave28 November 2025